Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Neurocrine Biosciences raises $34.2mm in IPO of 3.5mm shares.

Executive Summary

Neurocrine Biosciences (therapeutics for disorders of the central nervous and immune systems) has completed an initial public offering of 3.5mm shares priced at $10.50 per share, raising a net of $34.18mm.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
    • Drug Discovery Tools
      • Molecular Diversity
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies

Advertisement
UsernamePublicRestriction

Register